← brief for 2026-08-12 · Slowing decline

Potential nephroprotective mechanisms of orforglipron, an oral non-peptide GLP-1 receptor agonist.

Article No results yet Peer reviewed

Key takeaways

This paper reviews how orforglipron, a new GLP-1 diabetes pill you take by mouth, might protect the kidneys. It walks through the possible ways the drug could help kidney tissue. It does not report results from a study in people, so nothing is proven yet.

Who did this work

Ramadurgum P · Shah J · Shah E · Palmer BF

Source

Article · PubMed, the drug frontier · 2026 Jul 28
https://pubmed.ncbi.nlm.nih.gov/42582425/